After BGM Group Ltd. (NASDAQ: BGM) announced a large strategic asset acquisition, the company’s shares are on a sharp increase, climbing 22.78% to $8.84 as of the last check. This acquisition is a significant step forward for BGM, indicating its foray into the financial services, digital technology, and artificial intelligence (AI) sectors.
Purchasing AIX Inc. and Its Affiliates
The intelligent platform of AIX Inc. was purchased by BGM Group for around 1 billion RMB ($140 million), and the deal is anticipated to be finalized by the end of 2024. Shenzhen Xinbao Investment Management Co., Ltd. and RONS Intelligent Technology (Beijing) Co., Ltd., subsidiaries of AIX, are included in this deal. BGM is setting itself up for diverse growth by combining these businesses, broadening its scope beyond its present emphasis on biopharmaceuticals.
Innovations in Technology and Strategic Development
The banking and insurance industries have benefited greatly from AIX’s creative approach to AI and digital transformation. The acquisition is set to bolster BGM’s technological capabilities, facilitating the company’s strategic development and enhancing its ability to offer intelligent, efficient solutions in global markets. AIX’s digital platform, already successful in the insurance industry, will benefit from BGM’s broader market presence, unlocking new growth opportunities.
Expanding Healthcare and Insurance Horizons
This acquisition also aligns with national policies promoting elderly care and the expansion of the “silver economy.” The integration of AIX’s platform into the healthcare and pharmaceutical sectors will accelerate industry transformation, creating new opportunities for BGM in the global healthcare market. Additionally, AIX’s continued role as the primary user of the platform will ensure sustained innovation and development within the company.
Through this acquisition, BGM Group aims to create synergies between intelligent technology and biopharmaceuticals, positioning itself at the forefront of the global healthcare, medical, and insurance sectors. RONS Technology and Xinbao Investment will also gain from BGM’s extensive international network, creating additional growth prospects within the rapidly evolving healthcare and insurance industries.
